Phase II trial of ceftolozane/tazobactam in patients with nosocomial pneumonia.

Trial Profile

Phase II trial of ceftolozane/tazobactam in patients with nosocomial pneumonia.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2012

At a glance

  • Drugs Ceftolozane/tazobactam (Primary)
  • Indications Gram-negative infections; Nosocomial pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Sep 2012 Status changed from unconfirmed to recruiting.
    • 15 Sep 2011 Status changed from planning to unconfirmed.
    • 26 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top